Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis

Journal of Hepatology

Volumn 25, Issue 4, 1996, Pages 433-438

  Giostra, Fabrizio ^b   Manzin, Aldo ^b   Lenzi, Marco ^b   Francesconi, Raffaella ^b   Solforosi, Laura ^b   Manotti, Paolo ^b   Muratori, Luigi ^b   Zauli, Daniela ^b   Clementi, Massimo ^b   Bianchi, Francesco B ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

Anti liver kidney microsomal antibody; Competitive RT PCR; HCV genotype; Hepatitis C viremia

Indexed keywords

AUTOANTIBODY; DEFLAZACORT; INTERFERON; MICROSOME ANTIBODY; STEROID; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HISTOLOGY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA;

EID: 0030273503     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80201-7     Document Type: Article

References (27)

1. Rizzetto M, Swana G, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 15:1973;331-333.
2. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy VG, Grippon P, Opolon P, Bernuau J, Benhamou JP, Alaqil D. Chronic active hepatitis associated with anti-liver-kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 7:1987;1333-1339.
3. Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, Bianchi FB. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet. 335:1990;258-259.
4. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM, Opolon P, Homberg JC. Liver-kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 16:1992;630-636.
5. Michel R, Ritter A, Gerken G, Meyer zum Buschenfelde KH, Decher G, Manns M. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet. 339:1992;267-269.
6. Muratori L, Zauli D, Giostra F, Ballardini G, Lenzi M, Cassani F, Bianchi FB. LKM1 appearance in a HLA-DR3+ patients with chronic hepatitis C during interferon treatment. J Hepatol. 18:1993;259-260.
7. Mackie FD, Peakman M, Ma Y, Sallie R, Smith H, Davis ET, Mieli-Vergani G, Vergani D. Primary and secondary liver kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology. 106:1994;1672-1675.
8. Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol. 21:1994;199-203.
9. Gilliland G, Perrin S, Bunn F. Competitive PCR for quantitation of mRNA. Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR Protocols. 1992;60-69 Academic Press, Inc, San Diego.
10. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology. 18:1993;16-20.
11. Hagiwara H, Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastoenterology. 104:1993;877-883.
12. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sanchez-Pescador R, Detmer J, Wilber JC, Pagliaro L. Hepatitis C viremia in chronic liver disease: relationship to interferon-alfa or corticosteroid treatment. Hepatology. 19:1994;273-279.
13. Garson JA, Ring CJA, Tuke PW. Improvement of HCV genome detection with "short" PCR products. Lancet. 338:1991;1466-1467.
14. Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, Bianchi FB. Heterogeneity of liver/kidney microsomal antibody type 1 autoimmune hepatitis and hepatitis C virus related liver disease. Gut. 37:1995;406-412.
15. Bagnarelli P, Menzo S, Valenza A, Manzin A, Giacca M, Ancarani F, Scalise G, Varaldo PE, Clementi M. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patient and in patients with AIDS. J Virol. 66:1992;7328-7335.
16. Manzin A, Bagnarelli P, Menzo S, Giostra F, Brugia M, Francesconi R, Bianchi FB, Clementi M. Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol. 32:1994;1939-1944.
17. Chomczyski P, Sacchi H. Single-step method of RNA isolation by acid guanidium thiocymate-phenolchloroform extraction. Anal Biochem. 162:1897;156-159.
18. Abuaf N, Lunel F, Giral PH, Borotto E, Poupon R, Opolon P, Homberg JC. Non-organ specific autoantibodies associated to chronic C virus hepatitis. J Hepatol. 18:1993;359-364.
19. Lenzi M, Mantovani W, Cataleta M, Cassani F, Muratori L, Bianchi FB. HLA typing in autoimmune hepatitis (AI-CAM) type 2. J Hepatol. 16:1992;S59. (suppl 1).
20. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome p-450 monooxygenase. J Clin Invest. 88:1991;1370-1378.
21. Ma Y, Peakman M, Lenzi M, Thomas MG, Farzaneth F, Ballardini G, Cassani F, Mieli-Vergani G, Bianchi FB. Case against subclassification of type II autoimmune chronic active hepatitis. Lancet. 341:1993;60.
22. Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahasi K, Akahane Y, Yoshizawa H, Okamoto H, Tsuda F, Peterson DA, Muchmore E. Non-A non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet. 336:1990;1400-1403.
23. Puoti M, Spinetti A, Marin MG, Ravaggi A, Del Poggio P, Caremani M, Mazzotta F, Milo D, Cadeo GP, Orani AM, Soranzo L, Carosi G. Organ non-specific autoantibodies in patients with chronic C hepatitis: prevalence and clinical correlation. J Hepatol. 18:1993;S161. (suppl 1).
24. Gerotto M, Pontisso P, Giostra F, Francesconi R, Muratori L, Ballardini G, Lenzi M, Tisminetzky S, Bianci FB, Baralle FB, Alberti A. Analysis of hepatitis C virus genome in patients with anti-LKM1 autoantibodies. J Hepatol. 21:1994;273-276.
25. Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterol. 106:1994;1603-1610.
26. Pontisso P, Ruvoletto MG, Nicoletti M, Tisminetzky S, Gerotto M, Levrero M, Artini M, Baldi M, Ballardini G, Barbara L, Bonetti P, Brillanti S, Casarin C, Chemello L, Costanzo A, De Mitri S, Donada C, Felaco MF, Frezza M, Gaeta GB, Giostra F, Iervese T, Lo Iacono O, Milella M, Monno L, Negro F, Piccinino F, Russo G, Vaccaro A, Baralle F, Alberti A. Distribution of the three majior hepatitis C virus genotypes in Italy. A multicentre study of 495 patients with chronic hepatitis. J Viral Hepatitis. 2:1995;33-38.
27. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Nuewald PD, Wilber JC. Significance of serum hepatitis C RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.